-
Detailed Analysis Generate Full Report Add to Watchlist
Values as of: 2024-07-31
Values as of: 2024-07-31
The investment seeks to track the S&P Global 1200 Health Care Sector IndexTM. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. It may invest the remainder of its assets in certain futures, options and swap contracts, cash and cash equivalents, as well as in securities not included in the underlying index. The index measures the performance of companies that the index provider deems to be a part of the healthcare sector of the economy and that the index provider believes are important to global markets.
Company Website : www.ishares.com
Currency: USD
Country : USA
Inception Date: 13/11/2001
Primary Benchmark: S&P Global 1200 Healthcare Sector NR USD
Primary Index: MSCI ACWI NR USD
Gross Expense Ratio: 0.47%
Management Expense Ratio: 0.46 %
N/A
N/A
N/A
N/A
| Symbol | Name | Mer | Price(Change) | Market Cap |
|---|---|---|---|---|
| XLV | Health Care Select Sector SPDR.. | 0.13 % |
N/A |
USD 42.49B |
| FHLC | Fidelity® MSCI Health Care In.. | 0.08 % |
N/A |
USD 3.19B |
| FXH | First Trust Health Care AlphaD.. | 0.63 % |
N/A |
USD 1.30B |
| XHE | SPDR® S&P Health Care Equipme.. | 0.35 % |
N/A |
USD 0.23B |
| IDNA | iShares Genomics Immunology an.. | 0.00 % |
N/A |
USD 0.14B |
| SBIO | ALPS Medical Breakthroughs ETF | 0.50 % |
N/A |
USD 0.11B |
| XHS | SPDR® S&P Health Care Service.. | 0.35 % |
N/A |
USD 0.09B |
| HTEC | Robo Global® Healthcare Techn.. | 0.00 % |
N/A |
USD 0.06B |
| BBP | Virtus LifeSci Biotech Product.. | 0.79 % |
N/A |
USD 0.02B |
| BBC | Virtus LifeSci Biotech Clinica.. | 0.79 % |
N/A |
USD 0.01B |
| Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
|---|---|---|---|---|---|
| IXJ:AU | iShares Global Healthcare.. | 99.97 % | 0.00 % |
N/A |
USD 1.47B |
| XHC:CA | iShares Global Healthcare.. | 99.90 % | 0.65 % |
N/A |
CAD 0.67B |
| Market Performance vs. Industry/Classification (Health) | Market Performance vs. Exchange (NYSE Arca) | ||||||
| Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
| YTD | |||||||
| Capital Gain | 10.52% | 76% | C+ | 68% | D+ | ||
| Dividend Return | 0.78% | 80% | B- | 21% | F | ||
| Total Return | 11.29% | 76% | C+ | 65% | D | ||
| Trailing 12 Months | |||||||
| Capital Gain | 12.61% | 71% | C- | 67% | D+ | ||
| Dividend Return | 1.44% | 83% | B | 21% | F | ||
| Total Return | 14.05% | 76% | C+ | 62% | D | ||
| Trailing 5 Years | |||||||
| Capital Gain | 57.37% | 71% | C- | 75% | C | ||
| Dividend Return | 6.30% | 72% | C | 21% | F | ||
| Total Return | 63.67% | 71% | C- | 73% | C | ||
| Average Annual (5 Year Horizon) | |||||||
| Capital Gain | 7.84% | 67% | D+ | 65% | D | ||
| Dividend Return | 8.79% | 67% | D+ | 61% | D- | ||
| Total Return | 0.95% | 74% | C | 22% | F | ||
| Risk Return Profile | |||||||
| Volatility (Standard Deviation) | 10.29% | 95% | A | 76% | C+ | ||
| Risk Adjusted Return | 85.43% | 90% | A- | 95% | A | ||
| Market Capitalization | 1.32B | N/A | N/A | N/A | N/A | ||
| Target Price Action | Rating Action | Analyst | Rating | Price | Date |
|---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
There is nothing we particularly dislike
